Who owns IRONWOOD PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Ironwood Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ironwood Pharmaceuticals stock

Who bought or sold IRONWOOD PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Capstone Investment Advisors 48M $50M 19% Dec 2023
 View chart
Balyasny Asset Management 45M $47M 100% Dec 2023
 View chart
Braidwell 38M $40M 0% Dec 2023
 View chart
Tenor Capital Management 34M $36B 0% Dec 2023
 View chart
Shenkman Capital Management 17M $19B -2% Dec 2023
 View chart
DLD Asset Management 8.2M $8.7M 9% Dec 2023
 View chart
Calamos Advisors 5.0M $5.2M 0% Dec 2023
 View chart
Jane Street 3.0M $3.1M 0% Dec 2023
 View chart
Worth Venture Partners 1.6M $1.7M 58% Dec 2023
 View chart
Jpmorgan Chase & Co 807k $839k 26800% Dec 2023
 View chart
Bank of America Corporation 800k $834k 100% Dec 2023
 View chart
Citigroup 252k $263k -14% Dec 2023
 View chart
Bank of New York Mellon 200k $208k 100% Dec 2023
 View chart
Virtus Investment Advisers 42k $44k 100% Dec 2023
 View chart
Arkadios Wealth Advisors 11k $12k 0% Dec 2023
 View chart

Who sold out of Ironwood Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Sep 2023 19M $19M
III Capital Management Sep 2023 16M $16M
Bank Of Montreal Sep 2023 10M $9.7M
Wellesley Investment Advisors Sep 2023 3.7M $3.6B
D.A. Davidson & Co. Sep 2023 135k $132k
HPM Partners Sep 2023 36k $36k